Titre : Administration de la santé publique

Administration de la santé publique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Workforce
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Administration de la santé publique : Questions médicales les plus fréquentes", "headline": "Administration de la santé publique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Administration de la santé publique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-23", "dateModified": "2025-02-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Administration de la santé publique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Organisation et administration", "url": "https://questionsmedicales.fr/mesh/D009934", "about": { "@type": "MedicalCondition", "name": "Organisation et administration", "code": { "@type": "MedicalCode", "code": "D009934", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N04.452" } } }, "about": { "@type": "MedicalCondition", "name": "Administration de la santé publique", "alternateName": "Public Health Administration", "code": { "@type": "MedicalCode", "code": "D011635", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Stephen Thomson", "url": "https://questionsmedicales.fr/author/Stephen%20Thomson", "affiliation": { "@type": "Organization", "name": "ANU College of Law, The Australian National University, Canberra, Australia. stephen.thomson@anu.edu.au." } }, { "@type": "Person", "name": "Muhammad Zia Ud Din", "url": "https://questionsmedicales.fr/author/Muhammad%20Zia%20Ud%20Din", "affiliation": { "@type": "Organization", "name": "School of Public Administration, Central South University, Yuelu District, Changsha, Hunan, 410017, China." } }, { "@type": "Person", "name": "Xu Yuan Yuan", "url": "https://questionsmedicales.fr/author/Xu%20Yuan%20Yuan", "affiliation": { "@type": "Organization", "name": "School of Public Administration, Central South University, Yuelu District, Changsha, Hunan, 410017, China. xuyuanyuanj@163.com." } }, { "@type": "Person", "name": "Naqib Ullah Khan", "url": "https://questionsmedicales.fr/author/Naqib%20Ullah%20Khan", "affiliation": { "@type": "Organization", "name": "School of Public Administration, Central South University, Yuelu District, Changsha, Hunan, 410017, China. naqibkhan05@csu.edu.cn." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Geriatric Oncology as an Unmet Workforce Training Need in the United Kingdom-A Narrative Review by the British Oncology Network for Undergraduate Societies (BONUS) and the International Society of Geriatric Oncology (SIOG) UK Country Group.", "datePublished": "2023-09-28", "url": "https://questionsmedicales.fr/article/37835476", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/cancers15194782" } }, { "@type": "ScholarlyArticle", "name": "Artificial intelligence-aiding lab-on-a-chip workforce designed oral [3.1.0] bi and [4.2.0] tricyclic catalytic interceptors inhibiting multiple SARS-CoV-2 protomers assisted by double-shell deep learning.", "datePublished": "2024-08-27", "url": "https://questionsmedicales.fr/article/39193274", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1039/d4ra03965c" } }, { "@type": "ScholarlyArticle", "name": "\"They feel shame sometime, but that is why we need to talk to them…we need to tell them how important it is not to feel shame\": Hepatitis B related shame and improving hepatitis B care in Aboriginal and Torres Strait Islander communities in the Top End of the Northern Territory, according to the Aboriginal health workforce.", "datePublished": "2024-09-11", "url": "https://questionsmedicales.fr/article/39261962", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13690-024-01389-z" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Administration des services de santé", "item": "https://questionsmedicales.fr/mesh/D006298" }, { "@type": "ListItem", "position": 3, "name": "Organisation et administration", "item": "https://questionsmedicales.fr/mesh/D009934" }, { "@type": "ListItem", "position": 4, "name": "Administration de la santé publique", "item": "https://questionsmedicales.fr/mesh/D011635" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Administration de la santé publique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Administration de la santé publique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Administration de la santé publique", "description": "Comment évaluer l'efficacité d'un programme de santé publique ?\nQuels outils sont utilisés pour le diagnostic en santé publique ?", "url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Workforce&page=168#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Administration de la santé publique", "description": "Quels symptômes indiquent un problème de santé publique ?\nComment les symptômes de maladies affectent-ils la santé publique ?", "url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Workforce&page=168#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Administration de la santé publique", "description": "Quelles stratégies de prévention sont efficaces ?\nComment la prévention est-elle mesurée ?", "url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Workforce&page=168#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Administration de la santé publique", "description": "Quels traitements sont prioritaires en santé publique ?\nComment les traitements sont-ils administrés en santé publique ?", "url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Workforce&page=168#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Administration de la santé publique", "description": "Quelles complications peuvent survenir sans intervention en santé publique ?\nComment les complications affectent-elles les systèmes de santé ?", "url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Workforce&page=168#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Administration de la santé publique", "description": "Quels sont les principaux facteurs de risque en santé publique ?\nComment identifier les facteurs de risque dans une population ?", "url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Workforce&page=168#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer l'efficacité d'un programme de santé publique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité se mesure par des indicateurs de santé, des enquêtes et des analyses de données." } }, { "@type": "Question", "name": "Quels outils sont utilisés pour le diagnostic en santé publique ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des enquêtes épidémiologiques, des statistiques de santé et des études de cohorte sont utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent un problème de santé publique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des épidémies, des taux de mortalité élevés et des maladies infectieuses en hausse sont des indicateurs." } }, { "@type": "Question", "name": "Comment les symptômes de maladies affectent-ils la santé publique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Ils influencent les politiques de santé, la prévention et les ressources allouées aux soins." } }, { "@type": "Question", "name": "Quelles stratégies de prévention sont efficaces ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les campagnes de vaccination, l'éducation à la santé et les politiques de santé publique sont efficaces." } }, { "@type": "Question", "name": "Comment la prévention est-elle mesurée ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Elle est mesurée par la réduction des cas de maladies, l'augmentation des vaccinations et des dépistages." } }, { "@type": "Question", "name": "Quels traitements sont prioritaires en santé publique ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations, les traitements des maladies infectieuses et la santé maternelle sont prioritaires." } }, { "@type": "Question", "name": "Comment les traitements sont-ils administrés en santé publique ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont souvent fournis par des programmes de santé communautaire et des campagnes de sensibilisation." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir sans intervention en santé publique ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des épidémies, des résistances aux antibiotiques et des maladies chroniques peuvent survenir." } }, { "@type": "Question", "name": "Comment les complications affectent-elles les systèmes de santé ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Elles augmentent la charge sur les systèmes de santé, nécessitant plus de ressources et de personnel." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque en santé publique ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les comportements à risque, la pauvreté et l'accès limité aux soins sont des facteurs clés." } }, { "@type": "Question", "name": "Comment identifier les facteurs de risque dans une population ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Par des études épidémiologiques, des enquêtes et des analyses de données démographiques." } } ] } ] }

Sources (1673 au total)

Geriatric Oncology as an Unmet Workforce Training Need in the United Kingdom-A Narrative Review by the British Oncology Network for Undergraduate Societies (BONUS) and the International Society of Geriatric Oncology (SIOG) UK Country Group.

Cancer is a disease associated with ageing. Managing cancer in older adults may prove challenging owing to pre-existing frailty, comorbidity, and wider holistic needs, as well as the unclear benefits ...

"They feel shame sometime, but that is why we need to talk to them…we need to tell them how important it is not to feel shame": Hepatitis B related shame and improving hepatitis B care in Aboriginal and Torres Strait Islander communities in the Top End of the Northern Territory, according to the Aboriginal health workforce.

The Aboriginal health workforce has unique insights given their healthcare experience and interactions with their communities. The aims of this project were to explore their perceptions of hepatitis B... We conducted a qualitative study with guidance from the Menzies School of Health Research Infectious Diseases Indigenous Reference Group. The Aboriginal health workforce was asked to participate in se... There were fifteen semi-structured interviews with participants representing eight different communities. The experience of shame was reported by the Aboriginal health workforce to be common for indiv... Hepatitis B related shame was an important issue and impactful in Aboriginal and Torres Strait Islander communities in the Top End of the Northern Territory. There were many facets to shame in these c...